UPDATE : Monday, September 7, 2020
상단여백
Kang Stem, Heraeus Medical to develop anti-arthritis drug
Kang Stem Biotech 강스템바이오텍 said Thursday that it has signed an agreement wit...
by Lee Han-soo  |  2017-09-08 15:25
라인
Pharma Research Product releases home care cosmetics
Pharma Research Products 파마리서치프로덕트, a regenerative medicine company, said T...
by Lee Han-soo  |  2017-09-07 17:08
라인
Cellivery gets research funding from US Foundation
Cellivery, a protein-based drug discovery/development company, said Thursda...
by Lee Han-soo  |  2017-09-07 15:00
라인
Abclon confirms IPO at 10,000 won per share
Abclon, a biotechnology company, said Wednesday that it has confirmed its i...
by Lee Han-soo  |  2017-09-07 11:48
라인
Papers related to stem cell therapy rising worldwide
Seoul National University서울대학교, Catholic University of Korea가톨릭대학교, and Sch...
by Nam Doo-hyun  |  2017-09-06 16:45
라인
Wells Bio wins rights to make and sell ‘Strep A Plus’
Wells Bio 웰스바이오 said Tuesday it has obtained domestic manufacturing and sal...
by Lee Han-soo  |  2017-09-06 11:48
라인
Samsung Bioepis wins European sales approval for Imraldi
The European Commission (EC) has granted marketing authorization for Samsun...
by Lee Han-soo  |  2017-08-25 11:53
라인
Bio firms blame small R&D spending for low technology
Korea’s bio businesses cite “lack of R&D investment” as the main reason for...
by Nam Doo-hyun  |  2017-08-24 11:31
라인
Celltrion’s move to main stock market draws investor concern
The recent decision by Celltrion, Korea’s most successful biosimilar maker,...
by Nam Doo-hyun  |  2017-08-22 17:01
라인
Samsung Bioepis, Takeda agree to develop biosimilar drugs
Samsung Bioepis and Takeda Pharmaceutical have signed a strategic collabora...
by Lee Han-soo  |  2017-08-21 20:45
라인
iNtRON Biotechnology adds trial for super bacteria drug
iNtRON Biotechnology has gained approval to start an additional Phase 1b cl...
by Marian Chu  |  2017-08-21 16:15
라인
Korea lags 3.8 years behind US in medical technology
There are technological gaps of 3.8 years in the medical area and 4.3 years...
by Nam Doo-hyun  |  2017-08-21 12:11
라인
‘Bio industry should prepare for Nagoya Protocol’
As the Nagoya Protocol, an international agreement on using foreign biologi...
by Nam Doo-hyun  |  2017-08-17 19:57
라인
Monsanto, ToolGen sign licensing agreement for CRISPR
ToolGen툴젠, a local genome engineering company, has signed a global license ...
by Constance Williams  |  2017-08-17 16:32
라인
Medytox’s botulinum toxin hits record-high sales in Q2
The second-quarter sales of Medytox메디톡스, a local biopharmaceutical company,...
by Constance Williams  |  2017-08-16 10:29
라인
Cha Biotech turns profitable 3 years after equity spinoff
Cha Biotech차바이오텍, the nation's largest stem-cell drug pipeline, turned ...
by Constance Williams  |  2017-08-14 16:34
라인
‘Stress resilience research to open new bio area’
The research to develop stress resilience application technology could lead...
by Nam Doo-hyun  |  2017-08-14 16:33
라인
Weak competitiveness hinders biomedicine export to China
Korea’s pharmaceutical companies should urgently strengthen their abilities...
by Nam Doo-hyun  |  2017-08-08 14:04
라인
‘Biomedicine is 1 of 6 areas Korea, US leaders should tackle’
Biomedicine has emerged as one of six fields that President Moon Jae-in has...
by Nam Doo-hyun  |  2017-08-07 17:08
라인
Medipost’s stem-cell therapy hits record-high sales
Medipost Co. announced Thursday that the monthly sales of its stem-cell tre...
by Constance Williams  |  2017-08-04 11:25
-이전3132-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top